Search Results - "Hu, Qingzhong"
-
1
Cushing’s Syndrome: Development of Highly Potent and Selective CYP11B1 Inhibitors of the (Pyridylmethyl)pyridine Type
Published in Journal of medicinal chemistry (08-08-2013)“…Potent and selective CYP11B1 inhibitors could be promising therapeutics for the treatment of Cushing’s syndrome. Optimization of Ref 1…”
Get full text
Journal Article -
2
3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2
Published in PloS one (01-11-2012)“…Aldosterone synthase (CYP11B2) is a promising therapeutic target for the treatment of cardiovascular diseases related to abnormally high aldosterone levels. On…”
Get full text
Journal Article -
3
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer
Published in International Journal of Molecular Sciences (04-07-2013)“…Since 2010, six drugs have been approved for the treatment of castration-resistant prostate cancer, i.e., CYP17 inhibitor Abiraterone, androgen receptor…”
Get full text
Journal Article Book Review -
4
Highly Potent and Selective Nonsteroidal Dual Inhibitors of CYP17/CYP11B2 for the Treatment of Prostate Cancer To Reduce Risks of Cardiovascular Diseases
Published in Journal of medicinal chemistry (08-08-2013)“…Dual CYP17/CYP11B2 inhibitors are proposed as a novel strategy for the treatment of prostate cancer to reduce risks of cardiovascular diseases. Via a…”
Get full text
Journal Article -
5
Novel CYP17 inhibitors: Synthesis, biological evaluation, structure–activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls
Published in European journal of medicinal chemistry (01-07-2009)“…Recently, the steroidal CYP17 inhibitor Abiraterone entered phase II clinical trial for the treatment of androgen-dependent prostate cancer. As…”
Get full text
Journal Article -
6
Manipulations of phenylnorbornyl palladium species for multicomponent construction of a bridged polycyclic privileged scaffold
Published in Communications chemistry (29-10-2022)“…Hexahydromethanocarbazole is a privileged scaffold in the discovery of new drugs and photoactive organic materials due to its good balance between structural…”
Get full text
Journal Article -
7
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents
Published in Nature reviews. Urology (01-01-2014)“…Key Points 17α-Hydroxylase/C17,20-lyase (CYP17) is a steroidogenic enzyme that is central to the production of androgens, and is targeted by abiraterone in men…”
Get full text
Journal Article -
8
Chimera induced protein degradation: PROTACs and beyond
Published in European journal of medicinal chemistry (15-11-2020)“…Ubiquitin–proteasome system, autophagy-lysosome pathway and N-end rule pathway are crucial protein quality control mechanisms in human body. Hijacking these…”
Get full text
Journal Article -
9
Visible-Light-Promoted [4π + 2σ] Annulation of Dienes and Alkylamines via Dual Inert C(sp3)–H Bond Activation
Published in Organic letters (23-05-2024)“…Herein, visible-light-promoted [4π + 2σ] annulation of dienes and alkylamines was achieved via dual C(sp3)–H bond functionalization of alkylamines. The…”
Get full text
Journal Article -
10
Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis
Published in Drug discovery today (01-03-2023)“…•Many natural products ameliorate nonalcoholic fatty liver disease and nonalcoholic steatohepatitis via various mechanisms.•Alkaloids and terpenoids deserve…”
Get full text
Journal Article -
11
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases
Published in Journal of medicinal chemistry (26-06-2014)“…Besides the well-known roles of aldosterone as a mineralocorticoid in regulating homeostasis of electrolytes and volume, recent studies revealed that it is…”
Get full text
Journal Article -
12
Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase
Published in Journal of medicinal chemistry (08-09-2022)“…Inhibition of CYP11B1 is a promising therapy for severe diseases caused by excessive cortisol. Enantiomer discrimination provides clues to achieve selectivity…”
Get full text
Journal Article -
13
Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks
Published in Journal of medicinal chemistry (24-01-2013)“…The application of aromatase inhibitors to postmenopausal breast cancer patients increases the risk of cardiovascular diseases (CVD), which is believed to be…”
Get full text
Journal Article -
14
Selective Dual Inhibitors of CYP19 and CYP11B2: Targeting Cardiovascular Diseases Hiding in the Shadow of Breast Cancer
Published in Journal of medicinal chemistry (23-08-2012)“…Postmenopausal women are at high risk for cardiovascular diseases because of the estrogen deficiency. As for postmenopausal breast cancer patients, this risk…”
Get full text
Journal Article -
15
Proposing anti‐counterfeiting pharmacopoeia quality markers for Shenlingbaizhu granule based on UHPLC‐Q‐orbitrap‐MS identification
Published in Phytochemical analysis (01-03-2024)“…Introduction Shenlingbaizhu granule, a Traditional Chinese Medicine prescription comprising Renshen, Gancao, and Shanyao, is widely consumed in China nowadays…”
Get full text
Journal Article -
16
Sinomenine Derivatives: Synthesis, Antitumor Activity, and Apoptotic Induction in MCF‐7 Cells via IL‐6/PI3K/Akt/NF‐κB Signaling Pathway
Published in ChemMedChem (19-07-2022)“…Natural products have been widely considered as an important resource for new drugs or lead compounds. Sinomenine (SIN) and its derivatives exert antitumor…”
Get full text
Journal Article -
17
Fluorescence detecting glycopeptide antibiotics via a dynamic molecular switch
Published in Analytica chimica acta (15-03-2024)“…Glycopeptide antibiotics (GPAs) represented by vancomycin (VAN) are clinically used as a first-line treatment for serious infections caused by Gram-positive…”
Get full text
Journal Article -
18
Drug discovery for breast cancer and co-instantaneous cardiovascular disease: what is the future?
Published in Future medicinal chemistry (01-03-2013)Get more information
Journal Article -
19
Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016)
Published in Expert opinion on therapeutic patents (01-11-2016)“…Endogenous Cushing's syndrome (CS) is a set of disorders caused by chronic exposure to excess glucocorticoids induced by neuroendocrine tumors in pituitary,…”
Get more information
Journal Article -
20
Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis
Published in Journal of medicinal chemistry (24-03-2016)“…The inhibition of corticosteroid biosynthesis could be considered as an emerging strategy to reduce their abnormally high levels, and in this framework CYP11B1…”
Get full text
Journal Article